论文部分内容阅读
目的:探讨布美他尼联合白蛋白治疗重症急性胰腺炎(SAP)的临床疗效。方法:我们将58例SAP患者随机分为对照组(28例)和治疗组(30例),治疗组在常规治疗的基础上加用布美他尼和白蛋白早期联合使用,比较两组治疗效果。结果:治疗组的腹痛消失时间、体温、血淀粉酶、白细胞恢复正常时间、平均住院时间均短于对照组(P<0.05)。结论:白蛋白和布美他尼可缩短重症急性胰腺炎病程,减少并发症,可以常规早期使用。
Objective: To investigate the clinical efficacy of bumetanide combined with albumin in the treatment of severe acute pancreatitis (SAP). Methods: We randomly divided 58 SAP patients into control group (n = 28) and treatment group (n = 30). The treatment group was treated with early combination of bumetanide and albumin on the basis of routine treatment. effect. Results: The disappearance time of abdominal pain, body temperature, blood amylase, normal time of leukocyte recovery and average length of hospital stay in the treatment group were shorter than those in the control group (P <0.05). Conclusion: Albumin and bumetanide can shorten the course of severe acute pancreatitis and reduce complications, which can be routinely used early.